Gufic Biosciences Limited: board meetings

80 records, the earliest from 24 Aug 2009. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.

80 shown.

Sign in to see more, or upgrade your plan to see the full history. Sign in

DatePurposeNotes
14 Aug 2026Financial ResultsTo consider and approve the unaudited financial results for the quarter ended June 30, 2026 and other business matters
29 May 2026Financial Results/Dividend/Other business mattersTo consider and approve, inter alia, the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and financial year ended March 31, 2026, dividend and other business matters
13 Feb 2026Financial Results/Other business mattersTo consider and approve Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine months ended December 31, 2025 and other business matters
14 Nov 2025Financial Results/Other business mattersTo consider and approve the Unaudited financial results for the Quarter and half year ended September 30, 2025 and other business matters
13 Aug 2025Financial Results/Other business mattersTo consider and approve the unaudited financial results for the quarter ended Jun 30, 2025 and other business matters
30 May 2025Financial Results/Dividend/Other business mattersTo consider and approve, inter alia, Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2025, and to recommend a final dividend, if any, for the Financial Year 2024-25.
14 Feb 2025Financial Results/Other business mattersTo consider and approve, inter alia, the Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended December 31, 2024
14 Nov 2024Financial Results/Other business mattersTo consider and approve the financial results for the period ended September 30, 2024 and other business matters
14 Aug 2024Financial Results/Other business mattersTo consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2024 and other business matters
29 May 2024Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.